首页 > 最新文献

Frontiers in radiology最新文献

英文 中文
Development of a machine learning-based radiomics model of perivascular adipose tissue for predicting stroke risk in patients with asymptomatic carotid stenosis: a multicenter study. 基于机器学习的血管周围脂肪组织放射组学模型的开发,用于预测无症状颈动脉狭窄患者的卒中风险:一项多中心研究。
IF 2.3 Pub Date : 2026-01-21 eCollection Date: 2025-01-01 DOI: 10.3389/fradi.2025.1738298
Jinhong Sun, Cheng Ma, Guihan Lin, Weiyue Chen, Weiming Hu, Zhuohang Shi, Ting Zhao, Jie Zhang, Jianhua Wu, Xiongying Yi, Hua Yang, Suhong Ye, Lei Xu, Yongjun Chen, Weiqian Chen

Background: Our work aims to develop and evaluate a combined model that integrates clinical features, conventional computed tomography angiography (CTA) features, and radiomics features of perivascular adipose tissue (PVAT) to identify asymptomatic carotid stenosis (ACS) patients at high risk for short-term stroke.

Methods: We enrolled 582 ACS patients confirmed by CTA from three medical centers and divided them into a training set (n = 188), an internal validation set (n = 85), and two independent external validation sets (set 1, n = 157; set 2, n = 152). Radiomics features of PVAT were extracted from CTA images, and dimensionality reduction was performed to identify predictive features. Five machine learning classifiers were employed to construct radiomics models, and the model with the highest AUC was selected to generate the radiomics score (Rad-score). Clinical factors associated with stroke were determined using univariate and multivariate logistic regression analyses to construct a clinical model. A combined model integrating clinical factors and the Rad-score was subsequently developed, and a nomogram was created to provide a visual tool for stroke risk prediction. We assessed model performance comprehensively through calibration curves, discrimination analysis, reclassification, and clinical application.

Results: A total of nine optimal radiomics features were ultimately selected from the CTA images. Across the four datasets, the AUC values of the five classifier models ranged from 0.643 to 0.869, 0.716 to 0.826, 0.651 to 0.858, and 0.638 to 0.848, respectively, with the XGBoost model demonstrating the best performance. The combined model, incorporating hypertension, soft plaque, and the Rad-score as variables, achieved AUCs of 0.911, 0.868, 0.882, and 0.871, respectively, across the four datasets.

Conclusions: A combined model based on PVAT imaging features around carotid plaques can effectively predict the short-term stroke risk in ACS patients. This model may be expected to provide an important auxiliary tool for clinical prognosis assessment and treatment decisions, with potential clinical application value.

背景:我们的工作旨在建立和评估一种结合临床特征、常规计算机断层血管造影(CTA)特征和血管周围脂肪组织(PVAT)放射组学特征的联合模型,以识别短期卒中高风险的无症状颈动脉狭窄(ACS)患者。方法:我们招募了来自3个医疗中心的582例经CTA确诊的ACS患者,并将其分为训练集(n = 188)、内部验证集(n = 85)和两个独立的外部验证集(set 1, n = 157; set 2, n = 152)。从CTA图像中提取PVAT的放射组学特征,并进行降维以识别预测特征。采用5个机器学习分类器构建放射组学模型,选择AUC最高的模型生成放射组学评分(Rad-score)。采用单因素和多因素logistic回归分析确定与脑卒中相关的临床因素,构建临床模型。随后开发了一个整合临床因素和rad评分的组合模型,并创建了一个nomogram,为中风风险预测提供了一个可视化的工具。我们通过校准曲线、判别分析、再分类和临床应用对模型性能进行综合评价。结果:最终从CTA图像中选出了9个最佳放射组学特征。在4个数据集上,5种分类器模型的AUC值分别为0.643 ~ 0.869、0.716 ~ 0.826、0.651 ~ 0.858、0.638 ~ 0.848,其中XGBoost模型表现最佳。将高血压、软斑块和rad评分作为变量的联合模型在四个数据集上的auc分别为0.911、0.868、0.882和0.871。结论:基于颈动脉斑块周围PVAT成像特征的联合模型可有效预测ACS患者的短期卒中风险。该模型有望为临床预后评估和治疗决策提供重要的辅助工具,具有潜在的临床应用价值。
{"title":"Development of a machine learning-based radiomics model of perivascular adipose tissue for predicting stroke risk in patients with asymptomatic carotid stenosis: a multicenter study.","authors":"Jinhong Sun, Cheng Ma, Guihan Lin, Weiyue Chen, Weiming Hu, Zhuohang Shi, Ting Zhao, Jie Zhang, Jianhua Wu, Xiongying Yi, Hua Yang, Suhong Ye, Lei Xu, Yongjun Chen, Weiqian Chen","doi":"10.3389/fradi.2025.1738298","DOIUrl":"10.3389/fradi.2025.1738298","url":null,"abstract":"<p><strong>Background: </strong>Our work aims to develop and evaluate a combined model that integrates clinical features, conventional computed tomography angiography (CTA) features, and radiomics features of perivascular adipose tissue (PVAT) to identify asymptomatic carotid stenosis (ACS) patients at high risk for short-term stroke.</p><p><strong>Methods: </strong>We enrolled 582 ACS patients confirmed by CTA from three medical centers and divided them into a training set (<i>n</i> = 188), an internal validation set (<i>n</i> = 85), and two independent external validation sets (set 1, <i>n</i> = 157; set 2, <i>n</i> = 152). Radiomics features of PVAT were extracted from CTA images, and dimensionality reduction was performed to identify predictive features. Five machine learning classifiers were employed to construct radiomics models, and the model with the highest AUC was selected to generate the radiomics score (Rad-score). Clinical factors associated with stroke were determined using univariate and multivariate logistic regression analyses to construct a clinical model. A combined model integrating clinical factors and the Rad-score was subsequently developed, and a nomogram was created to provide a visual tool for stroke risk prediction. We assessed model performance comprehensively through calibration curves, discrimination analysis, reclassification, and clinical application.</p><p><strong>Results: </strong>A total of nine optimal radiomics features were ultimately selected from the CTA images. Across the four datasets, the AUC values of the five classifier models ranged from 0.643 to 0.869, 0.716 to 0.826, 0.651 to 0.858, and 0.638 to 0.848, respectively, with the XGBoost model demonstrating the best performance. The combined model, incorporating hypertension, soft plaque, and the Rad-score as variables, achieved AUCs of 0.911, 0.868, 0.882, and 0.871, respectively, across the four datasets.</p><p><strong>Conclusions: </strong>A combined model based on PVAT imaging features around carotid plaques can effectively predict the short-term stroke risk in ACS patients. This model may be expected to provide an important auxiliary tool for clinical prognosis assessment and treatment decisions, with potential clinical application value.</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":"5 ","pages":"1738298"},"PeriodicalIF":2.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12868272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effective deep convolutional neural network with attention mechanism for Alzheimer disease classification. 基于注意机制的深度卷积神经网络在阿尔茨海默病分类中的应用。
IF 2.3 Pub Date : 2026-01-14 eCollection Date: 2025-01-01 DOI: 10.3389/fradi.2025.1698760
Sathish Kumar Lakshmanan, Maragatharajan Muthusamy, Rajesh Kumar Dhanaraj, Aanjankumar Sureshkumar, Md Shohel Sayeed, Mohamed Yasin Noor Mohamed, Gopal Rathinam

Introduction: The reports from the Health Organizations indicates a sudden growth in neurocognitive disorders among middle-aged and elderly individuals. The accurate detection of Alzheimer's disease (AD) is essential for improving patient care, specifically during the early stages, where timely risk identification enables individuals to adopt preventive measures before irreversible brain damage occurs. Though, several studies have discovered about computerized approaches for AD, many existing techniques remain limited by inherent methodological constraints and insufficient clinical scrutiny. The current systems struggle to reliably predict the disorder in its initial stages. To reduce the need for frequent clinical visit and lower diagnostic costs, the machine learning and deep learning have emerged as powerful tools for AD detection.

Methods: This work reviews several research relevant on studies on AD and highlights how these computational techniques can support researchers in achieving more efficient and accurate early-stage detection. The Deep Convolutional Neural Network (Deep-CNN) with Attention mechanism is proposed to augment the spatial attention module and multi-class classification of Alzheimer disease stages. The model has trained and evaluated on the OASIS dataset using subject-level which satisfy statistical-validation and standard preprocessing.

Results: The proposed Deep-CNN and attention model focuses the model capacity on diagnostically relevant regions. The proposed model achieved an accuracy of 97%, which is higher than existing methods like SVM with kernels (90.5%), SVM Gaussian radial basis kernel (85%), and traditional CNN (93.5%).

Discussion: The visualizations of attention mechanism are used to increase the interpretability and demonstrate the attention maps which are align with known AD biomarkers. These results indicates that the attention-guided deep models can both improve multi-class MRI classification accuracy and provide clinically useful regional explanations.

导读:来自卫生组织的报告表明,神经认知障碍在中老年人群中突然增长。准确检测阿尔茨海默病(AD)对于改善患者护理至关重要,特别是在早期阶段,及时识别风险使个人能够在发生不可逆转的脑损伤之前采取预防措施。尽管有几项研究已经发现了计算机化治疗阿尔茨海默病的方法,但许多现有的技术仍然受到固有的方法限制和临床审查不足的限制。目前的系统很难可靠地预测疾病的初始阶段。为了减少频繁的临床访问和降低诊断成本,机器学习和深度学习已经成为AD检测的强大工具。方法:本工作回顾了几项与AD研究相关的研究,并强调了这些计算技术如何支持研究人员实现更有效和准确的早期检测。提出了一种具有注意机制的深度卷积神经网络(Deep- cnn)来增强阿尔茨海默病的空间注意模块和多类别分类。该模型在满足统计验证和标准预处理的主题级OASIS数据集上进行了训练和评估。结果:提出的深度cnn和注意力模型将模型能力集中在诊断相关区域。该模型的准确率为97%,高于现有的SVM带核(90.5%)、SVM高斯径向基核(85%)和传统CNN(93.5%)等方法。讨论:注意机制的可视化用于增加可解释性,并展示与已知AD生物标志物一致的注意图。这些结果表明,注意引导的深度模型既可以提高MRI的多类分类精度,又可以提供临床有用的区域解释。
{"title":"Effective deep convolutional neural network with attention mechanism for Alzheimer disease classification.","authors":"Sathish Kumar Lakshmanan, Maragatharajan Muthusamy, Rajesh Kumar Dhanaraj, Aanjankumar Sureshkumar, Md Shohel Sayeed, Mohamed Yasin Noor Mohamed, Gopal Rathinam","doi":"10.3389/fradi.2025.1698760","DOIUrl":"10.3389/fradi.2025.1698760","url":null,"abstract":"<p><strong>Introduction: </strong>The reports from the Health Organizations indicates a sudden growth in neurocognitive disorders among middle-aged and elderly individuals. The accurate detection of Alzheimer's disease (AD) is essential for improving patient care, specifically during the early stages, where timely risk identification enables individuals to adopt preventive measures before irreversible brain damage occurs. Though, several studies have discovered about computerized approaches for AD, many existing techniques remain limited by inherent methodological constraints and insufficient clinical scrutiny. The current systems struggle to reliably predict the disorder in its initial stages. To reduce the need for frequent clinical visit and lower diagnostic costs, the machine learning and deep learning have emerged as powerful tools for AD detection.</p><p><strong>Methods: </strong>This work reviews several research relevant on studies on AD and highlights how these computational techniques can support researchers in achieving more efficient and accurate early-stage detection. The Deep Convolutional Neural Network (Deep-CNN) with Attention mechanism is proposed to augment the spatial attention module and multi-class classification of Alzheimer disease stages. The model has trained and evaluated on the OASIS dataset using subject-level which satisfy statistical-validation and standard preprocessing.</p><p><strong>Results: </strong>The proposed Deep-CNN and attention model focuses the model capacity on diagnostically relevant regions. The proposed model achieved an accuracy of 97%, which is higher than existing methods like SVM with kernels (90.5%), SVM Gaussian radial basis kernel (85%), and traditional CNN (93.5%).</p><p><strong>Discussion: </strong>The visualizations of attention mechanism are used to increase the interpretability and demonstrate the attention maps which are align with known AD biomarkers. These results indicates that the attention-guided deep models can both improve multi-class MRI classification accuracy and provide clinically useful regional explanations.</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":"5 ","pages":"1698760"},"PeriodicalIF":2.3,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12847453/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146088298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-disciplinary diagnosis and management of verrucous venous malformation of the right knee: a case report. 右膝疣状静脉畸形多学科诊断与治疗1例。
IF 2.3 Pub Date : 2026-01-13 eCollection Date: 2025-01-01 DOI: 10.3389/fradi.2025.1686404
Varun H, Bhushan Madke, Prerit Sharma, Adarshlata Singh, Anurag Mittal, Vedashree Vedprakash Tiwari

Verrucous Venous Malformations (VVMs) are a rare subtype of Congenital Vascular Malformations (CVMs) characterised by a hyperkeratotic, verrucous surface. We present the case of a ten-year-old male with a VVM localised to the right knee, which presented as a gradually enlarging, asymptomatic lesion since birth. A comprehensive, multi-modality diagnostic workup was performed, including thorough clinical evaluation, dermoscopy, radiologic imaging (Plain radiograph, colour Doppler ultrasonography and magnetic resonance imaging) and histopathological analysis with hematoxylin and eosin staining, along with immunohistochemical staining for CD-34. The lesion exhibited characteristic features consistent with VVM. The patient was managed by percutaneous sclerotherapy to reduce lesion size. This case highlights the importance of a multidisciplinary strategy in the diagnosis and management of VVMs to improve clinical outcomes.

疣状静脉畸形(vvm)是一种罕见的先天性血管畸形(cvm)亚型,其特征是角化过度,疣状表面。我们提出的情况下,一个十岁的男性与VVM局部右膝,其表现为一个逐渐扩大,无症状的病变,因为出生。进行了全面、多模式的诊断检查,包括彻底的临床评估、皮肤镜检查、放射成像(x线平片、彩色多普勒超声和磁共振成像)和组织病理学分析(苏木精和伊红染色),以及CD-34的免疫组织化学染色。病变表现出与VVM一致的特征。患者接受经皮硬化治疗以减小病变大小。该病例强调了多学科策略在vvm诊断和管理中的重要性,以改善临床结果。
{"title":"Multi-disciplinary diagnosis and management of verrucous venous malformation of the right knee: a case report.","authors":"Varun H, Bhushan Madke, Prerit Sharma, Adarshlata Singh, Anurag Mittal, Vedashree Vedprakash Tiwari","doi":"10.3389/fradi.2025.1686404","DOIUrl":"https://doi.org/10.3389/fradi.2025.1686404","url":null,"abstract":"<p><p>Verrucous Venous Malformations (VVMs) are a rare subtype of Congenital Vascular Malformations (CVMs) characterised by a hyperkeratotic, verrucous surface. We present the case of a ten-year-old male with a VVM localised to the right knee, which presented as a gradually enlarging, asymptomatic lesion since birth. A comprehensive, multi-modality diagnostic workup was performed, including thorough clinical evaluation, dermoscopy, radiologic imaging (Plain radiograph, colour Doppler ultrasonography and magnetic resonance imaging) and histopathological analysis with hematoxylin and eosin staining, along with immunohistochemical staining for CD-34. The lesion exhibited characteristic features consistent with VVM. The patient was managed by percutaneous sclerotherapy to reduce lesion size. This case highlights the importance of a multidisciplinary strategy in the diagnosis and management of VVMs to improve clinical outcomes.</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":"5 ","pages":"1686404"},"PeriodicalIF":2.3,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12834784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146095048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond trauma: a case-based imaging review of spontaneous splenic rupture. 超越创伤:一个基于病例的自发性脾破裂影像学回顾。
IF 2.3 Pub Date : 2026-01-12 eCollection Date: 2025-01-01 DOI: 10.3389/fradi.2025.1715806
Federica Romano, Marina Alessandrella, Raffaella Lucci, Giorgio Bocchini, Mariano Scaglione, Stefania Tamburrini, Emanuele Muto, Giuseppina Dell'Aversano Orabona, Rosita Comune, Francesco Tiralongo, Graziella Di Grezia, Salvatore Masala, Giacomo Sica

Spontaneous splenic rupture (SSR) is a rare but potentially life-threatening condition, most commonly associated with underlying infectious, haematological, vascular, or neoplastic processes. Clinical presentation is often non-specific, which may lead to delayed diagnosis. Imaging, particularly contrast-enhanced computed tomography (CECT), plays a pivotal role in confirming splenic injury, identifying predisposing lesions, and guiding management. We present the case of a woman aged in her seventies with chronic atrial fibrillation on antiplatelet therapy who developed spontaneous splenic rupture secondary to an occult splenic hamartoma. Ultrasound demonstrated heterogeneous perisplenic fluid and altered splenic echotexture. CT showed a 3.5 cm laceration, moderate haemoperitoneum, and a solid lesion with delayed enhancement and no active bleeding. Follow-up CT revealed progressive organisation of haemoperitoneum and stable lesion morphology. The patient was initially managed non-operatively due to haemodynamic stability, but elective splenectomy was performed given the presence of a structural lesion and the need for chronic anticoagulation. The purpose of this article is to illustrate the diagnostic and management principles of SSR through a representative clinical case and to provide an updated review of imaging strategies, including emerging applications of radiomics and artificial intelligence (AI).

自发性脾破裂(SSR)是一种罕见但可能危及生命的疾病,最常与潜在的感染性、血液学、血管或肿瘤过程相关。临床表现通常是非特异性的,这可能导致诊断延迟。影像学,尤其是对比增强计算机断层扫描(CECT),在确认脾损伤、识别易感病变和指导治疗方面起着关键作用。我们报告一位70多岁的慢性房颤妇女,在接受抗血小板治疗后,发生了继发于隐匿性脾错构瘤的自发性脾破裂。超声显示脾周积液不均,脾回声改变。CT显示3.5 cm裂伤,中度腹膜出血,实性病变伴延迟强化,无活动性出血。随访CT显示腹膜出血组织进展,病变形态稳定。由于血流动力学稳定,患者最初采用非手术治疗,但由于存在结构性病变和需要慢性抗凝治疗,进行了选择性脾切除术。本文的目的是通过一个典型的临床病例来说明SSR的诊断和管理原则,并提供影像学策略的最新综述,包括放射组学和人工智能(AI)的新兴应用。
{"title":"Beyond trauma: a case-based imaging review of spontaneous splenic rupture.","authors":"Federica Romano, Marina Alessandrella, Raffaella Lucci, Giorgio Bocchini, Mariano Scaglione, Stefania Tamburrini, Emanuele Muto, Giuseppina Dell'Aversano Orabona, Rosita Comune, Francesco Tiralongo, Graziella Di Grezia, Salvatore Masala, Giacomo Sica","doi":"10.3389/fradi.2025.1715806","DOIUrl":"10.3389/fradi.2025.1715806","url":null,"abstract":"<p><p>Spontaneous splenic rupture (SSR) is a rare but potentially life-threatening condition, most commonly associated with underlying infectious, haematological, vascular, or neoplastic processes. Clinical presentation is often non-specific, which may lead to delayed diagnosis. Imaging, particularly contrast-enhanced computed tomography (CECT), plays a pivotal role in confirming splenic injury, identifying predisposing lesions, and guiding management. We present the case of a woman aged in her seventies with chronic atrial fibrillation on antiplatelet therapy who developed spontaneous splenic rupture secondary to an occult splenic hamartoma. Ultrasound demonstrated heterogeneous perisplenic fluid and altered splenic echotexture. CT showed a 3.5 cm laceration, moderate haemoperitoneum, and a solid lesion with delayed enhancement and no active bleeding. Follow-up CT revealed progressive organisation of haemoperitoneum and stable lesion morphology. The patient was initially managed non-operatively due to haemodynamic stability, but elective splenectomy was performed given the presence of a structural lesion and the need for chronic anticoagulation. The purpose of this article is to illustrate the diagnostic and management principles of SSR through a representative clinical case and to provide an updated review of imaging strategies, including emerging applications of radiomics and artificial intelligence (AI).</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":"5 ","pages":"1715806"},"PeriodicalIF":2.3,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12833092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146069081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robust radiomics: a review of guidelines for radiomics in medical imaging. 稳健放射组学:医学影像放射组学指南综述。
IF 2.3 Pub Date : 2026-01-12 eCollection Date: 2025-01-01 DOI: 10.3389/fradi.2025.1701110
Michele Avanzo, Paolo Soda, Marco Bertolini, Andrea Bettinelli, Tiziana Rancati, Joseph Stancanello, Osvaldo Rampado, Giovanni Pirrone, Annalisa Drigo

Introduction: Radiomics aims to develop image-based biomarkers by combining quantitative analysis of medical images with artificial intelligence (AI) through a robust, reproducible pipeline. Scientific societies, task groups, and consortia have published several guidelines to help researchers design robust radiomics studies. This review summarizes existing guidelines, recommendations, and regulations for designing radiomics studies that can lead to clinically adoptable biomarkers.

Methods: Relevant articles were identified through a PubMed systematic review using "radiomics" and "guideline" as keywords. Of 314 retrieved papers, after screening 99 articles were deemed relevant for extracting recommendations on developing image-based biomarkers. Additional guidelines were searched by the authors.

Results: We can synthesize the systematic review in the following high consensus recommendations divided into five major areas: a) Study Design: Carefully define the study rationale, objectives, and outcomes, ensuring the dataset is of adequate size and quality; b) Data Workflow: Use standardized protocols for image acquisition, reconstruction, preprocessing, and feature extraction-following IBSI guidelines where applicable; c) Model Development and Validation: Follow best practices for model development, including prevention of data leakage, dimensionality reduction, strategies to enhance model interpretability, and establish biological plausibility; d) Transparency and Reproducibility: Publish results with sufficient methodological details to ensure rigor and generalizability and promote open science by sharing codes and data; e) Quality and compliance: Evaluate study compliance with relevant guidelines and regulations using appropriate quality metrics.

Conclusion: Radiomics promises to offer clinically useful imaging biomarkers and can represent a significant step in personalized medicine. In the present systematic review we identified five key guidelines and regulations developed in recent years, specifically for radiomics or AI, that can guide the research community in designing and conducting radiomic studies that result in an imaging biomarker suitable for clinical practice.

Radiomics旨在通过强大的、可重复的管道,将医学图像的定量分析与人工智能(AI)相结合,开发基于图像的生物标志物。科学协会、任务小组和联盟已经发布了一些指导方针,以帮助研究人员设计可靠的放射组学研究。这篇综述总结了现有的放射组学研究设计的指南、建议和法规,这些研究可以导致临床可采用的生物标志物。方法:以“radiomics”和“guideline”为关键词,通过PubMed系统综述检索相关文献。在314篇检索到的论文中,筛选后认为99篇文章与提取开发基于图像的生物标志物的建议相关。作者检索了其他指南。结果:我们可以将系统评价综合为以下高共识建议,分为五个主要领域:a)研究设计:仔细定义研究的基本原理、目标和结果,确保数据集具有足够的规模和质量;b)数据工作流:使用标准化协议进行图像采集、重建、预处理和特征提取——适用时遵循IBSI指南;c)模型开发和验证:遵循模型开发的最佳实践,包括防止数据泄漏、降维、提高模型可解释性的策略,并建立生物合理性;d)透明度和可重复性:发表具有足够方法细节的结果,以确保严谨性和普遍性,并通过共享代码和数据促进开放科学;e)质量和符合性:使用适当的质量指标评估研究是否符合相关的指导方针和法规。结论:放射组学有望提供临床有用的成像生物标志物,并且可以代表个性化医疗的重要一步。在当前的系统综述中,我们确定了近年来制定的五个关键指南和法规,特别是针对放射组学或人工智能,它们可以指导研究界设计和开展放射组学研究,从而产生适合临床实践的成像生物标志物。
{"title":"Robust radiomics: a review of guidelines for radiomics in medical imaging.","authors":"Michele Avanzo, Paolo Soda, Marco Bertolini, Andrea Bettinelli, Tiziana Rancati, Joseph Stancanello, Osvaldo Rampado, Giovanni Pirrone, Annalisa Drigo","doi":"10.3389/fradi.2025.1701110","DOIUrl":"10.3389/fradi.2025.1701110","url":null,"abstract":"<p><strong>Introduction: </strong>Radiomics aims to develop image-based biomarkers by combining quantitative analysis of medical images with artificial intelligence (AI) through a robust, reproducible pipeline. Scientific societies, task groups, and consortia have published several guidelines to help researchers design robust radiomics studies. This review summarizes existing guidelines, recommendations, and regulations for designing radiomics studies that can lead to clinically adoptable biomarkers.</p><p><strong>Methods: </strong>Relevant articles were identified through a PubMed systematic review using \"radiomics\" and \"guideline\" as keywords. Of 314 retrieved papers, after screening 99 articles were deemed relevant for extracting recommendations on developing image-based biomarkers. Additional guidelines were searched by the authors.</p><p><strong>Results: </strong>We can synthesize the systematic review in the following high consensus recommendations divided into five major areas: a) Study Design: Carefully define the study rationale, objectives, and outcomes, ensuring the dataset is of adequate size and quality; b) Data Workflow: Use standardized protocols for image acquisition, reconstruction, preprocessing, and feature extraction-following IBSI guidelines where applicable; c) Model Development and Validation: Follow best practices for model development, including prevention of data leakage, dimensionality reduction, strategies to enhance model interpretability, and establish biological plausibility; d) Transparency and Reproducibility: Publish results with sufficient methodological details to ensure rigor and generalizability and promote open science by sharing codes and data; e) Quality and compliance: Evaluate study compliance with relevant guidelines and regulations using appropriate quality metrics.</p><p><strong>Conclusion: </strong>Radiomics promises to offer clinically useful imaging biomarkers and can represent a significant step in personalized medicine. In the present systematic review we identified five key guidelines and regulations developed in recent years, specifically for radiomics or AI, that can guide the research community in designing and conducting radiomic studies that result in an imaging biomarker suitable for clinical practice.</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":"5 ","pages":"1701110"},"PeriodicalIF":2.3,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12833238/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146069100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applications, image analysis, and interpretation of computer vision in medical imaging. 计算机视觉在医学成像中的应用、图像分析和解释。
IF 2.3 Pub Date : 2026-01-09 eCollection Date: 2025-01-01 DOI: 10.3389/fradi.2025.1733003
Yasunari Matsuzaka, Masayuki Iyoda

This review summarizes the current advances, applications, and research prospects of computer vision in advancing medical imaging. Computer vision in healthcare has revolutionized medical practice by increasing diagnostic accuracy, improving patient care, and increasing operational efficiency. Likewise, deep learning algorithms have advanced medical image analysis, significantly improved healthcare outcomes and transforming diagnostic processes. Specifically, convolutional neural networks are crucial for modern medical image segmentation, enabling the accurate, efficient analysis of various imaging modalities and helping enhance computer-aided diagnosis and treatment planning. Computer vision algorithms have demonstrated remarkable capabilities in detecting various diseases. Artificial intelligence (AI) systems can identify lung nodules in chest computed tomography scans at a sensitivity comparable to that of experienced radiologists. Computer vision can analyze brain scans to detect problems such as aneurysms and tumors or areas affected by diseases such as Alzheimer's. In summary, computer vision in medical imaging is significantly improving diagnostic accuracy, efficiency, and patient outcomes across a range of medical specialties.

本文综述了计算机视觉在推进医学成像方面的最新进展、应用和研究前景。医疗保健领域的计算机视觉通过提高诊断准确性、改善患者护理和提高操作效率,彻底改变了医疗实践。同样,深度学习算法具有先进的医学图像分析,显着改善了医疗保健结果并改变了诊断过程。具体来说,卷积神经网络对于现代医学图像分割至关重要,它能够对各种成像模式进行准确、高效的分析,并有助于增强计算机辅助诊断和治疗计划。计算机视觉算法在检测各种疾病方面表现出了非凡的能力。人工智能(AI)系统可以在胸部计算机断层扫描中识别肺结节,其灵敏度与经验丰富的放射科医生相当。计算机视觉可以分析脑部扫描,以发现动脉瘤、肿瘤或受阿尔茨海默病等疾病影响的区域等问题。总之,医学成像中的计算机视觉在一系列医学专业中显著提高了诊断的准确性、效率和患者的治疗效果。
{"title":"Applications, image analysis, and interpretation of computer vision in medical imaging.","authors":"Yasunari Matsuzaka, Masayuki Iyoda","doi":"10.3389/fradi.2025.1733003","DOIUrl":"10.3389/fradi.2025.1733003","url":null,"abstract":"<p><p>This review summarizes the current advances, applications, and research prospects of computer vision in advancing medical imaging. Computer vision in healthcare has revolutionized medical practice by increasing diagnostic accuracy, improving patient care, and increasing operational efficiency. Likewise, deep learning algorithms have advanced medical image analysis, significantly improved healthcare outcomes and transforming diagnostic processes. Specifically, convolutional neural networks are crucial for modern medical image segmentation, enabling the accurate, efficient analysis of various imaging modalities and helping enhance computer-aided diagnosis and treatment planning. Computer vision algorithms have demonstrated remarkable capabilities in detecting various diseases. Artificial intelligence (AI) systems can identify lung nodules in chest computed tomography scans at a sensitivity comparable to that of experienced radiologists. Computer vision can analyze brain scans to detect problems such as aneurysms and tumors or areas affected by diseases such as Alzheimer's. In summary, computer vision in medical imaging is significantly improving diagnostic accuracy, efficiency, and patient outcomes across a range of medical specialties.</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":"5 ","pages":"1733003"},"PeriodicalIF":2.3,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12827770/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146054570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosing acute myocarditis in the emergency department-advancing cardiac MRI with a focus on low-field MR applications. 急诊科急性心肌炎的诊断——以低场磁共振成像为重点推进心脏MRI的应用。
IF 2.3 Pub Date : 2026-01-08 eCollection Date: 2025-01-01 DOI: 10.3389/fradi.2025.1652004
Ehsan Karimialavijeh, Latika Giri, Eduardo Baettig, Muhammad Umair

Acute myocarditis is an inflammatory condition of the myocardium, often triggered by viral infections, autoimmune diseases, or toxins. It can lead to arrhythmias, heart failure, and sudden cardiac death. Early and accurate diagnosis is crucial for timely management and preventing complications. It poses a significant diagnostic challenge in emergency departments (EDs) due to nonspecific symptoms, overlapping features with conditions like acute coronary syndrome, and limitations of conventional diagnostics. Cardiac magnetic resonance imaging (CMR) is the gold standard for noninvasive diagnosis, using the 2018 Modified Lake Louise Criteria (mLLC). However, high-field CMR (1.5-3T) faces barriers in EDs, such as longer scan times, higher cost, lack of accessibility, and contraindications in patients with implantable devices, severe kidney disease, or hemodynamic instability. Low-field MRI (<1.5T) offers advantages in portability, safety, and cost while reducing susceptibility artifacts. Recent advances in AI-driven image reconstruction (e.g., LoHiResGAN, U-net) address low signal-to-noise ratios, enabling cine imaging, strain analysis, and parametric mapping at 0.55T. Studies show that low-field CMR can detect subclinical myocarditis and predict outcomes, with ECV measurements at 0.55T strongly correlating with 1.5T (r = 0.91), demonstrating comparable reliability. By integrating low-field CMR into ED protocols, clinicians can improve early detection of occult myocarditis, guide risk stratification, and reduce long-term morbidity and healthcare costs. Standardization of imaging workflows and AI-enhanced protocols will further bridge diagnostic gaps, particularly in resource-limited settings. This review highlights low-field CMR's potential to redefine acute myocarditis management, balancing diagnostic precision with practicality in emergency care.

急性心肌炎是一种心肌炎症,通常由病毒感染、自身免疫性疾病或毒素引起。它会导致心律失常、心力衰竭和心源性猝死。早期和准确的诊断对于及时处理和预防并发症至关重要。由于非特异性症状、与急性冠状动脉综合征等疾病的重叠特征以及传统诊断的局限性,它对急诊科(EDs)的诊断提出了重大挑战。心脏磁共振成像(CMR)是使用2018年修订的路易斯湖标准(mLLC)进行无创诊断的金标准。然而,高场CMR (1.5-3T)在急诊科中面临障碍,如扫描时间较长、成本较高、缺乏可及性,以及有植入装置、严重肾脏疾病或血流动力学不稳定患者的禁忌症。低场MRI (r = 0.91),显示出相当的可靠性。通过将低场CMR整合到ED方案中,临床医生可以提高隐匿性心肌炎的早期发现,指导风险分层,降低长期发病率和医疗成本。成像工作流程的标准化和人工智能增强协议将进一步弥合诊断差距,特别是在资源有限的情况下。这篇综述强调了低场CMR在重新定义急性心肌炎管理方面的潜力,平衡了急诊护理的诊断准确性和实用性。
{"title":"Diagnosing acute myocarditis in the emergency department-advancing cardiac MRI with a focus on low-field MR applications.","authors":"Ehsan Karimialavijeh, Latika Giri, Eduardo Baettig, Muhammad Umair","doi":"10.3389/fradi.2025.1652004","DOIUrl":"10.3389/fradi.2025.1652004","url":null,"abstract":"<p><p>Acute myocarditis is an inflammatory condition of the myocardium, often triggered by viral infections, autoimmune diseases, or toxins. It can lead to arrhythmias, heart failure, and sudden cardiac death. Early and accurate diagnosis is crucial for timely management and preventing complications. It poses a significant diagnostic challenge in emergency departments (EDs) due to nonspecific symptoms, overlapping features with conditions like acute coronary syndrome, and limitations of conventional diagnostics. Cardiac magnetic resonance imaging (CMR) is the gold standard for noninvasive diagnosis, using the 2018 Modified Lake Louise Criteria (mLLC). However, high-field CMR (1.5-3T) faces barriers in EDs, such as longer scan times, higher cost, lack of accessibility, and contraindications in patients with implantable devices, severe kidney disease, or hemodynamic instability. Low-field MRI (<1.5T) offers advantages in portability, safety, and cost while reducing susceptibility artifacts. Recent advances in AI-driven image reconstruction (e.g., LoHiResGAN, U-net) address low signal-to-noise ratios, enabling cine imaging, strain analysis, and parametric mapping at 0.55T. Studies show that low-field CMR can detect subclinical myocarditis and predict outcomes, with ECV measurements at 0.55T strongly correlating with 1.5T (<i>r</i> = 0.91), demonstrating comparable reliability. By integrating low-field CMR into ED protocols, clinicians can improve early detection of occult myocarditis, guide risk stratification, and reduce long-term morbidity and healthcare costs. Standardization of imaging workflows and AI-enhanced protocols will further bridge diagnostic gaps, particularly in resource-limited settings. This review highlights low-field CMR's potential to redefine acute myocarditis management, balancing diagnostic precision with practicality in emergency care.</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":"5 ","pages":"1652004"},"PeriodicalIF":2.3,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12823832/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146054970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Report: Metastasis of low-grade endometrial stromal sarcoma to the inferior vena cava and right atrium: a case of successful one-stage surgical resection with favorable early outcome. 病例报告:低级别子宫内膜间质肉瘤转移至下腔静脉及右心房:一期手术切除成功1例,早期预后良好。
IF 2.3 Pub Date : 2026-01-07 eCollection Date: 2025-01-01 DOI: 10.3389/fradi.2025.1723859
Jinglian Tu, Xiaopei Xu, Fengbo Huang

Low-grade endometrial stromal sarcoma (LGESS) is a rare uterine malignancy; metastasis to the inferior vena cava (IVC) and right atrium is exceptionally rare and presents significant diagnostic and therapeutic challenges. We report the case of a 37-year-old woman presenting with progressive abdominal mass enlargement, palpitations, and dyspnea. She had undergone a hysteroscopic resection for presumed uterine myoma one year prior, which was subsequently re-evaluated as LGESS. Multimodal imaging comprising 18F-FDG PET/CT, MRI, CT, and echocardiography was implemented for systemic staging and hemodynamic assessment, then revealed a solid uterine mass involving the adnexa (FIGO Stage IVB) and identified hypermetabolic tumor thrombi extending from the IVC into the right atrium and pulmonary arteries. A coordinated one-stage radical resection was performed, involving total hysterectomy and removal of intracardiac thrombi under cardiopulmonary bypass. Postoperative pathology and immunohistochemistry confirmed LGESS (CD10+, ER+, PR+) with extensive lymphovascular invasion. The patient recovered uneventfully with no residual disease on follow-up and commenced adjuvant letrozole therapy. This case highlights the necessity of multimodal imaging for accurate staging of complex vascular involvement and demonstrates that aggressive one-stage surgical management is a viable strategy to achieve locoregional control and favorable early outcomes for advanced LGESS with cardiac metastasis.

低级别子宫内膜间质肉瘤是一种罕见的子宫恶性肿瘤;转移到下腔静脉(IVC)和右心房是非常罕见的,提出了重大的诊断和治疗挑战。我们报告的情况下,37岁的妇女表现为进行性腹部肿块扩大,心悸,呼吸困难。一年前,她接受了宫腔镜切除子宫肌瘤,随后被重新评估为LGESS。多模式成像包括18F-FDG PET/CT、MRI、CT和超声心动图,用于系统分期和血流动力学评估,然后发现一个累及附件的实性子宫肿块(FIGO IVB期),并发现高代谢肿瘤血栓从下腔静脉延伸到右心房和肺动脉。进行协调的一期根治性切除,包括全子宫切除和体外循环下的心内血栓清除。术后病理及免疫组化证实LGESS (CD10+, ER+, PR+)伴广泛淋巴血管浸润。患者在随访中恢复平稳,无残留疾病,并开始辅助来曲唑治疗。本病例强调了多模式成像对复杂血管受累准确分期的必要性,并表明积极的一期手术治疗是实现局部控制和晚期LGESS合并心脏转移的良好早期预后的可行策略。
{"title":"Case Report: Metastasis of low-grade endometrial stromal sarcoma to the inferior vena cava and right atrium: a case of successful one-stage surgical resection with favorable early outcome.","authors":"Jinglian Tu, Xiaopei Xu, Fengbo Huang","doi":"10.3389/fradi.2025.1723859","DOIUrl":"10.3389/fradi.2025.1723859","url":null,"abstract":"<p><p>Low-grade endometrial stromal sarcoma (LGESS) is a rare uterine malignancy; metastasis to the inferior vena cava (IVC) and right atrium is exceptionally rare and presents significant diagnostic and therapeutic challenges. We report the case of a 37-year-old woman presenting with progressive abdominal mass enlargement, palpitations, and dyspnea. She had undergone a hysteroscopic resection for presumed uterine myoma one year prior, which was subsequently re-evaluated as LGESS. Multimodal imaging comprising <sup>18</sup>F-FDG PET/CT, MRI, CT, and echocardiography was implemented for systemic staging and hemodynamic assessment, then revealed a solid uterine mass involving the adnexa (FIGO Stage IVB) and identified hypermetabolic tumor thrombi extending from the IVC into the right atrium and pulmonary arteries. A coordinated one-stage radical resection was performed, involving total hysterectomy and removal of intracardiac thrombi under cardiopulmonary bypass. Postoperative pathology and immunohistochemistry confirmed LGESS (CD10+, ER+, PR+) with extensive lymphovascular invasion. The patient recovered uneventfully with no residual disease on follow-up and commenced adjuvant letrozole therapy. This case highlights the necessity of multimodal imaging for accurate staging of complex vascular involvement and demonstrates that aggressive one-stage surgical management is a viable strategy to achieve locoregional control and favorable early outcomes for advanced LGESS with cardiac metastasis.</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":"5 ","pages":"1723859"},"PeriodicalIF":2.3,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12819723/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146031796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultra-lightweight uncertainty-aware ensemble for large-scale multi-class medical MRI diagnosis. 用于大规模多级医学MRI诊断的超轻量不确定性感知集成。
IF 2.3 Pub Date : 2025-12-19 eCollection Date: 2025-01-01 DOI: 10.3389/fradi.2025.1723272
Sowad Rahman, Fahmid Al Farid, Mahe Zabin, Jia Uddin, Hezerul Abdul Karim

This paper introduces an Ultra-Lightweight Uncertainty-Aware Ensemble (UALE) model for large-scale multi-class medical MRI diagnosis, evaluated on the 2024 Benchmark Diagnostic MRI and Medical Imaging Dataset containing 40 classes and 33,616 images. The model integrates five specialized micro-expert networks, each designed to capture distinct MRI features, and combines them using a confidence-weighted ensemble mechanism enhanced with variance-based uncertainty quantification for robust, reliable predictions. With only 0.05M parameters and 0.18 GFLOPs, UALE achieves high efficiency and competitive performance among ultra-lightweight models with an accuracy of 69.1% and an F1 score of 68.3%. Besides lightweight models, the paper offers an extensive analysis and performance comparison with fifteen state-of-the-art models, discusses various datasets, elaborates on uncertainty estimates pertaining to the clinical trustworthiness of the models and possible clinical deployment, and highlights trade-offs and avenues for future work in economically constrained settings. The extreme compactness and reliability of the UALE affords it unique utility in scalable medical diagnostics suitable for low-resource clinical settings and portable imaging devices, such as rural hospitals.

本文介绍了一种用于大规模多类别医学MRI诊断的超轻量级不确定性感知集成(UALE)模型,并在包含40类和33,616张图像的2024基准诊断MRI和医学成像数据集上进行了评估。该模型集成了五个专门的微专家网络,每个网络都设计用于捕获不同的MRI特征,并使用基于方差的不确定性量化增强的置信度加权集成机制将它们结合起来,以实现稳健、可靠的预测。UALE仅使用0.05M参数和0.18 GFLOPs,以69.1%的准确率和68.3%的F1分数在超轻量车型中实现了高效率和竞争力。除了轻量级模型,本文还对15个最先进的模型进行了广泛的分析和性能比较,讨论了各种数据集,详细阐述了与模型的临床可信度和可能的临床部署有关的不确定性估计,并强调了在经济受限环境下未来工作的权衡和途径。UALE的极端紧凑性和可靠性使其在可扩展的医疗诊断中具有独特的实用性,适用于资源匮乏的临床环境和便携式成像设备,如农村医院。
{"title":"Ultra-lightweight uncertainty-aware ensemble for large-scale multi-class medical MRI diagnosis.","authors":"Sowad Rahman, Fahmid Al Farid, Mahe Zabin, Jia Uddin, Hezerul Abdul Karim","doi":"10.3389/fradi.2025.1723272","DOIUrl":"10.3389/fradi.2025.1723272","url":null,"abstract":"<p><p>This paper introduces an Ultra-Lightweight Uncertainty-Aware Ensemble (UALE) model for large-scale multi-class medical MRI diagnosis, evaluated on the 2024 Benchmark Diagnostic MRI and Medical Imaging Dataset containing 40 classes and 33,616 images. The model integrates five specialized micro-expert networks, each designed to capture distinct MRI features, and combines them using a confidence-weighted ensemble mechanism enhanced with variance-based uncertainty quantification for robust, reliable predictions. With only 0.05M parameters and 0.18 GFLOPs, UALE achieves high efficiency and competitive performance among ultra-lightweight models with an accuracy of 69.1% and an F1 score of 68.3%. Besides lightweight models, the paper offers an extensive analysis and performance comparison with fifteen state-of-the-art models, discusses various datasets, elaborates on uncertainty estimates pertaining to the clinical trustworthiness of the models and possible clinical deployment, and highlights trade-offs and avenues for future work in economically constrained settings. The extreme compactness and reliability of the UALE affords it unique utility in scalable medical diagnostics suitable for low-resource clinical settings and portable imaging devices, such as rural hospitals.</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":"5 ","pages":"1723272"},"PeriodicalIF":2.3,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12757377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145901760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histogram analysis of diffusion-weighted imaging with a fractional order calculus model in breast cancer: diagnostic performance and associations with prognostic factors. 乳腺癌分数阶微积分模型弥散加权成像的直方图分析:诊断性能及其与预后因素的关系。
IF 2.3 Pub Date : 2025-12-18 eCollection Date: 2025-01-01 DOI: 10.3389/fradi.2025.1664740
Bo Hu, Caili Tang, Qilan Hu, Xu Yan, Tao Ai

Objective: This study aims to evaluate the diagnostic performance of diffusion-weighted imaging (DWI) with a fractional order calculus (FROC) model for differentiating breast lesions and to explore the associations between FROC/apparent diffusion coefficient (ADC)-derived diffusion metrics and prognostic biomarkers and molecular subtypes in breast cancer.

Methods: This retrospective study included 147 patients with 159 histopathology-confirmed lesions who underwent multi-b DWI using simultaneous multi-slice (SMS) readout-segmented echo-planar imaging (rs-EPI) at 3.0 T. Whole-lesion histograms were computed for mono-exponential ADC and FROC parameters (D, β, μ). The Mann-Whitney U test was used to compare the histogram metrics of each diffusion parameter between the benign and malignant groups and between groups with different prognostic biomarkers and molecular subtypes. The Kruskal-Wallis test was used to compare the histogram metrics of each DWI-derived parameter among the different molecular subtypes. The Spearman rank correlation analysis was employed to characterize correlations between diffusion parameters and prognostic biomarkers. The diagnostic performance of each DWI-derived parameter in differentiating breast lesions was assessed using receiver operating characteristic (ROC) analysis.

Results: Interobserver reproducibility was excellent (intra-class correlation coefficient 0.827-0.928). Central tendency histogram metrics (10th, 90th percentiles, mean, median) of ADC and FROC parameters were higher in benign than malignant lesions, whereas skewness (all models) and entropy/kurtosis (ADC, D, μ) were lower in benign lesions (all p < 0.05, except β-skewness). The histogram metrics of ADC-median, DFROC-mean, and DFROC-median showed similar diagnostic performance. The values of ADC-mean, DFROC-10%, DFROC-mean, DFROC-median, βFROC-10%, βFROC-mean, and βFROC-median were significantly lower in the estrogen receptor (ER)-positive group compared with those in the ER-negative group. The tumors with progesterone receptor (PR)-negative status showed significantly higher βFROC-10%, βFROC-mean, and βFROC-median values than those of tumors with PR-positive status. The values of DFROC-skewness, βFROC-10%, and βFROC-mean exhibited significant differences in differentiating the triple-negative and luminal subtypes.

Conclusions: FROC-based histogram analysis yields diagnostic performance comparable to ADC for benign vs. malignant classification, while providing richer associations with ER/PR status, proliferation, and nodal involvement, reflecting microstructural heterogeneity not captured by mono-exponential diffusion.

目的:本研究旨在评估分数阶微积分(FROC)模型的弥散加权成像(DWI)对乳腺病变的诊断价值,并探讨FROC/表观弥散系数(ADC)衍生的弥散指标与乳腺癌预后生物标志物和分子亚型之间的关系。方法:本回顾性研究纳入147例经组织病理学证实的159个病变,采用3.0 T同步多层(SMS)读数分段回声平面成像(rs-EPI)进行多重DWI检查。计算单指数ADC和FROC参数(D, β, μ)的全病变直方图。使用Mann-Whitney U检验比较良性组和恶性组之间以及具有不同预后生物标志物和分子亚型的组之间每个扩散参数的直方图度量。采用Kruskal-Wallis检验比较不同分子亚型dwi衍生参数的直方图度量。采用Spearman秩相关分析来表征扩散参数与预后生物标志物之间的相关性。使用受试者工作特征(ROC)分析评估每个dwi衍生参数在鉴别乳腺病变中的诊断性能。结果:观察者间重现性极好(类内相关系数0.827 ~ 0.928)。良性病变的ADC和FROC参数的集中趋势直方图指标(第10、90百分位、平均值、中位数)高于恶性病变,而良性病变的偏度(所有模型)和熵/峰度(ADC、D、μ)较低(所有p FROC平均值和dfroc中位数显示相似的诊断性能)。雌激素受体(ER)阳性组ADC-mean、DFROC-10%、DFROC-mean、DFROC-median、βFROC-10%、βFROC-mean、βFROC-median值均显著低于ER阴性组。孕激素受体(PR)阴性肿瘤的βFROC-10%、β froc均值和β froc中位数均明显高于PR阳性肿瘤。dfroc - skeness、βFROC-10%和βFROC-mean在三阴性和管腔亚型的区分上存在显著差异。结论:基于froc的直方图分析在良恶性分类方面的诊断性能与ADC相当,同时提供了与ER/PR状态、增殖和淋巴结受累的更丰富的关联,反映了单指数扩散未捕捉到的微观结构异质性。
{"title":"Histogram analysis of diffusion-weighted imaging with a fractional order calculus model in breast cancer: diagnostic performance and associations with prognostic factors.","authors":"Bo Hu, Caili Tang, Qilan Hu, Xu Yan, Tao Ai","doi":"10.3389/fradi.2025.1664740","DOIUrl":"10.3389/fradi.2025.1664740","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to evaluate the diagnostic performance of diffusion-weighted imaging (DWI) with a fractional order calculus (FROC) model for differentiating breast lesions and to explore the associations between FROC/apparent diffusion coefficient (ADC)-derived diffusion metrics and prognostic biomarkers and molecular subtypes in breast cancer.</p><p><strong>Methods: </strong>This retrospective study included 147 patients with 159 histopathology-confirmed lesions who underwent multi-b DWI using simultaneous multi-slice (SMS) readout-segmented echo-planar imaging (rs-EPI) at 3.0 T. Whole-lesion histograms were computed for mono-exponential ADC and FROC parameters (D, β, μ). The Mann-Whitney <i>U</i> test was used to compare the histogram metrics of each diffusion parameter between the benign and malignant groups and between groups with different prognostic biomarkers and molecular subtypes. The Kruskal-Wallis test was used to compare the histogram metrics of each DWI-derived parameter among the different molecular subtypes. The Spearman rank correlation analysis was employed to characterize correlations between diffusion parameters and prognostic biomarkers. The diagnostic performance of each DWI-derived parameter in differentiating breast lesions was assessed using receiver operating characteristic (ROC) analysis.</p><p><strong>Results: </strong>Interobserver reproducibility was excellent (intra-class correlation coefficient 0.827-0.928). Central tendency histogram metrics (10th, 90th percentiles, mean, median) of ADC and FROC parameters were higher in benign than malignant lesions, whereas skewness (all models) and entropy/kurtosis (ADC, D, μ) were lower in benign lesions (all <i>p</i> < 0.05, except β-skewness). The histogram metrics of ADC-median, D<sub>FROC</sub>-mean, and D<sub>FROC</sub>-median showed similar diagnostic performance. The values of ADC-mean, D<sub>FROC</sub>-10%, D<sub>FROC</sub>-mean, D<sub>FROC</sub>-median, β<sub>FROC</sub>-10%, β<sub>FROC</sub>-mean, and β<sub>FROC</sub>-median were significantly lower in the estrogen receptor (ER)-positive group compared with those in the ER-negative group. The tumors with progesterone receptor (PR)-negative status showed significantly higher β<sub>FROC</sub>-10%, β<sub>FROC</sub>-mean, and β<sub>FROC</sub>-median values than those of tumors with PR-positive status. The values of D<sub>FROC</sub>-skewness, β<sub>FROC</sub>-10%, and β<sub>FROC</sub>-mean exhibited significant differences in differentiating the triple-negative and luminal subtypes.</p><p><strong>Conclusions: </strong>FROC-based histogram analysis yields diagnostic performance comparable to ADC for benign vs. malignant classification, while providing richer associations with ER/PR status, proliferation, and nodal involvement, reflecting microstructural heterogeneity not captured by mono-exponential diffusion.</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":"5 ","pages":"1664740"},"PeriodicalIF":2.3,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12756068/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145901807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in radiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1